Yayın:
Comparison of antiproliferative and apoptotic effects of a novel proteasome inhibitor MLN2238 with bortezomib on K562 chronic myeloid leukemia cells

Sadeleştirilmiş öğe sayfası
dc.contributor.authorEngür, Selin
dc.contributor.authorDikmen, Miriş
dc.contributor.authorÖZTÜRK, YUSUF
dc.contributor.orcid0000-0003-1534-8117
dc.contributor.orcid0009-0000-1090-0166
dc.contributor.orcid0000-0002-9488-0891
dc.date.accessioned2025-11-13T10:07:42Z
dc.date.issued2015-12-15
dc.identifier.doihttps://doi.org/10.3109/08923973.2015.1122616
dc.identifier.endpage97
dc.identifier.issn0892-3973
dc.identifier.issue2
dc.identifier.openalexW2253425397
dc.identifier.startpage87
dc.identifier.urihttps://hdl.handle.net/11421/3206
dc.identifier.urihttps://doi.org/10.3109/08923973.2015.1122616
dc.identifier.volume38
dc.language.isoen
dc.relation.ispartofImmunopharmacology and Immunotoxicology
dc.rightsrestrictedAccess
dc.subjectBortezomib
dc.subjectProteasome inhibitor
dc.subjectApoptosis
dc.subjectPharmacology
dc.subjectMyeloid leukemia
dc.subjectIxazomib
dc.subjectProteasome
dc.subjectCytotoxic T cell
dc.subjectCancer research
dc.subjectK562 cells
dc.subjectBiology
dc.subjectMedicine
dc.subjectImmunology
dc.subjectCarfilzomib
dc.subjectIn vitro
dc.subjectBiochemistry
dc.subjectMultiple myeloma
dc.subject.sdg3
dc.titleComparison of antiproliferative and apoptotic effects of a novel proteasome inhibitor MLN2238 with bortezomib on K562 chronic myeloid leukemia cells
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5021293880
local.authorid.openalexA5042645402
local.authorid.openalexA5012641576

Dosyalar

Koleksiyonlar

Publications